LOMBARD MED INC's ticker is EVAR and the CUSIP is G55598109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $531 | – | 1,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 3,473,452 | $22,056,000 | 6.26% |
| Aisling Capital LLC | 886,363 | $5,761,000 | 0.87% |
| PURA VIDA INVESTMENTS, LLC | 336,025 | $2,184,000 | 0.80% |
| Verition Fund Management LLC | 29,902 | $194,000 | 0.04% |
| FIL Ltd | 786,997 | $5,116,000 | 0.02% |
| Invesco Ltd. | 6,317,851 | $41,066,000 | 0.02% |
| Spark Investment Management LLC | 12,400 | $78,000 | 0.01% |
| GLG Partners LP | 60,892 | $396,000 | 0.01% |
| Alyeska Investment Group, L.P. | 100,391 | $653,000 | 0.01% |
| MOORE CAPITAL MANAGEMENT, LP | 45,000 | $293,000 | 0.01% |